openPR Logo
Press release

ACE Inhibitors Market Size, Trends & Forecast 2024-2033

ACE Inhibitors Market Size

ACE Inhibitors Market Size

The Business Research Company recently released a comprehensive report on the Global ACE Inhibitors Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The ace inhibitors market size has grown steadily in recent years. It will grow from $6.9 billion in 2023 to $7.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to risen cardiovascular disease incidence, increased aging population, clinical effectiveness and safety profile, prevalence of diabetes, regulatory endorsement and guidelines.

The ace inhibitors market size is expected to see strong growth in the next few years. It will grow to $9 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growing global burden of cardiovascular diseases, expanding hypertension treatment guidelines, advancements in combination therapies, focus on heart failure management, rising awareness and healthcare access. Major trends in the forecast period include focus on kidney protection, preference for renin-angiotensin system inhibitors, generic competition and pricing pressures, patient-centric approaches in healthcare, regulatory updates and safety considerations.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/ace-inhibitors-global-market-report

Market Drivers and Trends:

The increasing prevalence of hypertension disorders is expected to drive the growth of the ACE inhibitors market going forward. High blood pressure, medically known as hypertension, is a condition characterized by elevated pressure within the blood vessels. ACE inhibitors, also known as angiotensin-converting enzyme inhibitors, are a group of medications utilized to treat and control hypertension. These medications function by relaxing the blood vessels, resulting in a reduction in blood pressure and an improvement in blood flow. For instance, in March 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, approximately 1.28 billion adults between the ages of 30 and 79 were affected by hypertension worldwide, with a majority (two-thirds) residing in low- and middle-income nations. In the past 30 years, there has been an increase of 650 million people aged 30-79 who have hypertension. An estimated 46% of adults with hypertension are unaware of their condition, lacking a diagnosis. Over the last 30 years, the number of adults aged 30-79 who have hypertension has increased by 650 million. An estimated 46% of persons with hypertension are unaware of their condition since they are not diagnosed. Therefore, the increasing prevalence of hypertension disorders is driving the growth of the ACE inhibitors market.

Product innovations are a key trend gaining popularity in the ACE inhibitors market. Major companies operating in the ACE inhibitors market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in February 2023, Travere Therapeutics, a US-based biopharmaceutical company, announced FDA approval of FILSPARI™ (sparsentan), a first-of-its-kind non-immunosuppressive therapy for use in patients with IgA nephropathy (IgAN). These treatments include systemic glucocorticoids, angiotensin-converting enzyme (ACE) inhibitors, and antihypertensive medications, including angiotensin-receptor blockers (ARBs). It is the only non-immunosuppressive therapy approved and a once-daily oral medicine designed to treat adults with primary IgAN at risk of rapid disease development and who typically have a UPCR of less than 1.5 g/g and proteinuria.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10671&type=smp

Major Key Players of the Market:

Pfizer Inc.;Novartis AG;Johnson & Johnson Private Limited; Merck KGaA;Sanofi S.A.;Bayer AG;United Therapeutics Corporation;Teva Pharmaceutical Industries Ltd.;Bristol-Myers Squibb Co.;Takeda Pharmaceuticals Company;Daiichi Sankyo Company Ltd.;UCB Schwarz Pharma Inc.;Solvay Pharmaceuticals B.V.;Endo International plc;Otto Brandes GmbH;Sun Pharmaceutical Industries Ltd.;Boehringer Ingelheim;Bausch Health Companies Inc.;Dr. Reddy's Laboratories;Abbott Laboratories;Eli Lilly and Company;Cipla Limited; GlaxoSmithKline plc;Cadila Healthcare Limited;AbbVie Inc.; Mylan N.V.; Sandoz Group AG;Accord Healthcare Ltd.;AstraZeneca plc;Lupin Limited;Macleods Pharmaceuticals Limited;Zydus lifescience Ltd.;Apotex Inc.

ACE Inhibitors Market 2024 Key Insights:

• The ace inhibitors market will grow to $9 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%.
• Rising Hypertension Rates Fuel The Growth Of Ace Inhibitors Market
• Product Innovations Drive Growth In Ace Inhibitors Market
• North America was the largest region in the ACE inhibitors market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10671&type=smp

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ACE Inhibitors Market Size, Trends & Forecast 2024-2033 here

News-ID: 3746245 • Views:

More Releases from The Business research company

n-Butanol Market to Grow at 5% CAGR, Reaching $4.52 Billion by 2029
n-Butanol Market to Grow at 5% CAGR, Reaching $4.52 Billion by 2029
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. n-Butanol Market Outlook: How is the Market Expected to Grow by 2025? The market size for n-butanol has been experiencing a consistent growth in the past few years. The market is projected to expand from $3.55 billion in 2024 to $3.72 billion in 2025, demonstrating a Compound Annual Growth Rate
Acrylic Powder Coating Market is Anticipated to Expand upto $1.98 Billion in 2029
Acrylic Powder Coating Market is Anticipated to Expand upto $1.98 Billion in 202 …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What Is the Forecasted Market Growth Rate of the Acrylic Powder Coating Industry? The market for acrylic powder coating has seen sustained growth over the past few years. Expectations are for it to expand from a value of $1.53 billion in 2024 to $1.6 billion in 2025, reflecting a 4.5% compound
L-lactide Industry Expected to Reach $2.64 Billion by 2029 at 12.7% CAGR
L-lactide Industry Expected to Reach $2.64 Billion by 2029 at 12.7% CAGR
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. L-lactide Market Value Projection: How Much Will the Market Size by 2025? The market size for l-lactide has experienced quick expansion in the past few years. The value is projected to increase from $1.45 billion in 2024 to $1.63 billion in 2025, representing a compound annual growth rate (CAGR) of 12.6%.
Graphene Market is Anticipated to Expand upto $3.41 Billion in 2029
Graphene Market is Anticipated to Expand upto $3.41 Billion in 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What Is the Forecasted Market Growth Rate of the Graphene Industry? In the latest years, the size of the graphene market has seen a substantial expansion. It is projected that it will rise from $1.32 billion in 2024 to $1.6 billion in 2025, with a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for ACE

ChillReleaf Cooling Ace Reviews: Coolizi Cooling Ace, The Top Rated Portable Air …
As temperatures rise and the summer sun blazes on, staying cool without racking up high electricity bills has become a growing concern for many households. Enter the Coolizi Cooling Ace, also known as the ChillReleaf Cooling Ace - a game-changing portable cooling solution designed for modern comfort and efficiency. This compact, lightweight, and stylish device delivers powerful cooling performance without the bulk or complexity of traditional air conditioners. Whether you're
Coolizi cooling Ace reviews - Coolizi Cooling Ace portable air cooler
[United States] - June 2025 - With record-breaking temperatures sweeping across the U.S., consumers are turning to smart cooling solutions that are effective, affordable, and energy-efficient. One product standing out from the crowd is the Coolizi Cooling Ace - a compact, powerful portable air cooler that's already gone viral online. From TikTok to tech blogs, the buzz around Coolizi Cooling Ace Reviews is growing rapidly, and for good reason. Click Below
ChillReleaf Cooling Ace Reviews 2025
Introduction In the sweltering heat of summer, finding an efficient and affordable cooling solution becomes paramount. The ChillReleaf Cooling Ace positions itself as a portable, energy-efficient alternative to traditional air conditioning units. Marketed as a bladeless, whisper-quiet device capable of cooling the air by up to 20°F in just 30 seconds, it promises rapid relief without the hefty electricity bills associated with conventional ACs . Design and Build Quality The Cooling Ace boasts
Coldeez Cooling ACE Australia (Updated): Don't Buy Coldeez Cooling ACE In Austra …
Not long ago, Coldeez Cooling ACE was designed and immediately made available for sales in Australia, mainly on the official website at discounted prices. Like most portable air coolers, many people have been questioning its authenticity despite being one of the best selling portable air coolers in Australia. It is so amazing how fast it has gone viral despite being relatively new and the competition from some top brands. Based
ACE Health Solutions Goes Live
ACE Health Solutions (AHS), a full-service consulting company enabling independent physicians and multi-specialty clinics to optimize business practices, launched in late 2012. Since the launch, AHS has been working with local practices helping them implement electronic medical records (EMR) services and providing an array of other services. J. Chawla, ACE’s CEO and Founder, who has several years of experience working for successful healthcare organizations, is quoted in saying “the healthcare
Ace Appliance Repair
Ace Appliance Repair, an appliance repair service in Pittsburgh, PA, recently partnered with Prospect Genius, an online marketing firm, to assist area homeowners searching for low-priced appliance repairs. Through targeted search engine optimization (SEO) tactics, ACE Appliance repair is making it easier and quicker for local homeowners to locate them when performing Internet searches for appliance repair services and other needs, such as water heater installation. Joe Sazio, owner and founder